Mucosal-Associated Invariant T Cells Confer Protection in Pediatric Metabolic dysfunction-Associated Steatotic Liver Disease
This study reveals that activated mucosal-associated invariant T (MAIT) cells, which expand in the periphery of pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) patients via MR1-dependent and IL12/IL18-dependent pathways and migrate to the liver through the CXCR6-CXCL16 axis, play a protective role by reducing hepatic lipid accumulation, suggesting their potential as biomarkers and therapeutic targets.